{
    "title": "Eli Lilly says other COVID-19 antibody drug trials ongoing after study halted for safety concern",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8840057/Eli-Lilly-says-COVID-19-antibody-drug-trials-ongoing-study-halted-safety-concern.html",
    "date": "2020-10-14",
    "keywords": [
        "trial",
        "safety",
        "drug",
        "study",
        "covid19",
        "board",
        "carl",
        "odonnell",
        "wednesday",
        "antibody",
        "therapy",
        "treatment",
        "nih",
        "status",
        "boundary",
        "company",
        "lycov555",
        "request",
        "statement",
        "dsmb",
        "michael",
        "co",
        "coronavirus",
        "track",
        "governmentrun",
        "tuesday",
        "pause",
        "activ3",
        "issue",
        "institutes",
        "health",
        "difference",
        "placebo",
        "detail",
        "theyve",
        "level",
        "richard",
        "chaisson",
        "professor",
        "medicine",
        "johns",
        "ill",
        "remdesivir",
        "emergency",
        "use",
        "authorization",
        "eua",
        "bamlanivimab",
        "illness",
        "staff",
        "food",
        "administration",
        "comment",
        "application",
        "dualantibody",
        "regeneron",
        "president",
        "clearance",
        "tantamount",
        "video",
        "week",
        "hospital",
        "type",
        "disease",
        "spokeswoman",
        "partnership",
        "institute",
        "allergy",
        "division",
        "oversight",
        "panel",
        "data",
        "problem",
        "judgment",
        "caution",
        "reporting",
        "nomiyama",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}